Having assessed the situation on its core markets, the fit of the company's near-term development portfolio and the existing operating portfolio ...
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today on ...
CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the Company will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 1:30 pm PT in San ...
GMT/BST Britvic plc 7 January 2025 DIRECTOR/PDMR ...
Senior Biotechnology and Specialty Healthcare Financial Executive Brings Extensive Experience in Leading Acquisition and Organic Growth ...
Published extended data from the phase 2 EMPhASIS trial of vidofludimus calcium in relapsing-remitting MS in the peer reviewed journal, Neurology® Neuroimmunology & Neuroinflammation, an official ...
Company to Host International Roadshow the Week of January 13, 2025 LOS ANGELES, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: ...
Die Schweizer Großbank UBS hat NVIDIA auf "Buy" mit einem Kursziel von 185 US-Dollar belassen. Im vorbörslichen NASDAQ-Handel ...
Der Luxusautohersteller Rolls-Royce will seine Produktionsstätte in Großbritannien erweitern, um der steigenden Nachfrage ...
Die jüngste Euphorie bei Quantencomputing-Aktien erhält durch neue Aussagen von NVIDIA-CEO Jensen Huang einen deutlichen ...
Das wäre der Verdienst eines frühen Orange-Einstiegs gewesen.
Wer vor Jahren in Bechtle eingestiegen ist, hätte nun so viel Verlust gemacht.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback